FLAG with Bortezomib in Children and Adolescents with Relapsed/Refractory Acute Myeloid Leukemia in a Resource-Limited Setting: A Single-Center Experience from India
FLAG-bortezomib regimen could help in pediatric and adolescent relapsed AML to achieve a remission comparable with other regimen in low- and middle-income countries, highlighting its potential.
Authors
- Himangi Tak
- Maharshi Trivedi (ORCID: https://orcid.org/0000-0002-4872-7159)
- Chinmay Doctor
- Rajan Yadav (ORCID: https://orcid.org/0000-0002-1551-8414)
- Dipesh Dave (ORCID: https://orcid.org/0009-0003-0986-4227)
- Harsha P. Panchal
Institutions
- Gujarat Cancer & Research Institute (IN)
Publication Details
- Journal
- South Asian Journal of Cancer
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1055/s-0045-1809167
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00